A discussion on the role of the cabozantinib and nivolumab regimen in the treatment of advanced RCC.
Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice
Drs Alter and Diamond muse about the unmet needs in advanced RCC treatment.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Pembrolizumab Plus Enfortumab Vedotin in MIBC
2
FDA Approves Subcutaneous Isatuximab Delivered Via On-Body Delivery System for Multiple Myeloma
3
Risvutatug Rezetecan Shows OS Benefit Over Topotecan in Relapsed SCLC
4
FDA Flashback: Breast Cancer Decisions and News From June 2026
5